D'Amaro J, Bach F H, Van Rood J J, Rimm A A, Bortin M M
Lancet. 1984 Nov 24;2(8413):1176-8. doi: 10.1016/s0140-6736(84)92741-7.
Frequencies of HLA A, B, C, and DR antigens were calculated in 1009 leukaemia patients, all of whom had been treated with bone-marrow transplantation and reported to the International Bone Marrow Transplant Registry. Cw3 (relative risk = 2 X 26, p = 0 X 00002) and Cw4 (relative risk = 2 X 18, p = 0 X 00003) were significantly associated with acute leukaemia (p values adjusted for multiple comparisons). Cw3 (relative risk = 2 X 97, p = 0 X 00002) and Cw4 (relative risk = 2 X 10, p = 0 X 004) were also significantly associated with acute lymphoblastic leukaemia and Cw4 was significantly associated with acute myelogenous leukaemia (relative risk = 2 X 39, p = 0 X 0003). The data suggest that Cw3 and Cw4 may be markers for leukaemia susceptibility genes, genes that code for low immune responsiveness to putative leukaemia viruses, or genes that regulate the response to chemotherapy and, therefore, the attainment of remission, since most of these patients underwent transplantation during remission.
对1009例白血病患者的HLA A、B、C和DR抗原频率进行了计算,所有患者均接受过骨髓移植治疗,并已向国际骨髓移植登记处报告。Cw3(相对风险=2×26,p=0×00002)和Cw4(相对风险=2×18,p=0×00003)与急性白血病显著相关(p值经多重比较调整)。Cw3(相对风险=2×97,p=0×00002)和Cw4(相对风险=2×10,p=0×004)也与急性淋巴细胞白血病显著相关,Cw4与急性髓细胞白血病显著相关(相对风险=2×39,p=0×0003)。数据表明,Cw3和Cw4可能是白血病易感基因的标志物,这些基因编码对假定白血病病毒的低免疫反应性,或者是调节对化疗的反应从而影响缓解率的基因,因为这些患者中的大多数在缓解期接受了移植。